Sanofi Valuation

SNYNF Stock  USD 105.85  0.50  0.47%   
At this time, the company appears to be overvalued. Sanofi has a current Real Value of $86.57 per share. The regular price of the company is $105.85. Our model measures the value of Sanofi from inspecting the company fundamentals such as Shares Outstanding of 1.25 B, return on equity of 0.0959, and Operating Margin of 0.26 % as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
105.85
Please note that Sanofi's price fluctuation is very steady at this time. Calculation of the real value of Sanofi is based on 3 months time horizon. Increasing Sanofi's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Sanofi pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Sanofi. Since Sanofi is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Sanofi Pink Sheet. However, Sanofi's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  105.85 Real  86.57 Hype  105.85 Naive  107.85
The real value of Sanofi Pink Sheet, also known as its intrinsic value, is the underlying worth of Sanofi Company, which is reflected in its stock price. It is based on Sanofi's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Sanofi's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
86.57
Real Value
116.44
Upside
Estimating the potential upside or downside of Sanofi helps investors to forecast how Sanofi pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Sanofi more accurately as focusing exclusively on Sanofi's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
91.0299.27107.51
Details
Hype
Prediction
LowEstimatedHigh
103.78105.85107.92
Details
Naive
Forecast
LowNext ValueHigh
105.78107.85109.92
Details

Sanofi Total Value Analysis

Sanofi is at this time estimated to have takeover price of 135.37 B with market capitalization of 120.25 B, debt of 14.86 B, and cash on hands of 6.9 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Sanofi fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
135.37 B
120.25 B
14.86 B
6.9 B

Sanofi Investor Information

About 47.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.6. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Sanofi has Price/Earnings To Growth (PEG) ratio of 1.63. The entity recorded earning per share (EPS) of 5.77. The firm last dividend was issued on the 6th of May 2022. Sanofi had 1005:1000 split on the 6th of May 2022. Sanofi is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.

Sanofi Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Sanofi has an asset utilization ratio of 36.43 percent. This implies that the Company is making $0.36 for each dollar of assets. An increasing asset utilization means that Sanofi is more efficient with each dollar of assets it utilizes for everyday operations.

Sanofi Ownership Allocation

Sanofi shows a total of 1.25 Billion outstanding shares. 30% of Sanofi outstanding shares are owned by institutional holders. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.

Sanofi Profitability Analysis

The company reported the revenue of 45.39 B. Net Income was 6.72 B with profit before overhead, payroll, taxes, and interest of 31.69 B.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Sanofi's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Sanofi and how it compares across the competition.

About Sanofi Valuation

The pink sheet valuation mechanism determines Sanofi's current worth on a weekly basis. Our valuation model uses a comparative analysis of Sanofi. We calculate exposure to Sanofi's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Sanofi's related companies.
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. Sanofi was founded in 1973 and is headquartered in Paris, France. Sanofi-Aventis operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 95442 people.

8 Steps to conduct Sanofi's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Sanofi's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Sanofi's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Sanofi's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Sanofi's revenue streams: Identify Sanofi's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Sanofi's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Sanofi's growth potential: Evaluate Sanofi's management, business model, and growth potential.
  • Determine Sanofi's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Sanofi's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Sanofi Growth Indicators

Investing in growth stocks can be very risky. If the company such as Sanofi does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding1.3 B
Quarterly Earnings Growth Y O Y0.293
Forward Price Earnings10.3306

Complementary Tools for Sanofi Pink Sheet analysis

When running Sanofi's price analysis, check to measure Sanofi's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanofi is operating at the current time. Most of Sanofi's value examination focuses on studying past and present price action to predict the probability of Sanofi's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanofi's price. Additionally, you may evaluate how the addition of Sanofi to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Transaction History
View history of all your transactions and understand their impact on performance